When british regulators were forced to suspend the license of a flu vaccine plant in liverpool operated by the chiron corporation due to concerns over bacterial contamination, the number of flu vaccines available in the united states market decreased by 48 million doses. This was nearly half of the total supply of vaccines in the market.
